References
1. Pelzer C, Kassner I, Matentzoglu K, Singh RK, Wollscheid HP, Scheffner M, Schmidtke G, Groettrup M. 2007. UBE1L2, a novel E1 enzyme specific for ubiquitin. J Biol Chem. Aug 10;282(32):23010-23014.
2. Jin J, Li X, Gygi SP, Harper JW. 2007. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature. June 28;447(7148):1135-1138.
3. Chiu YH, Sun Q, Chen ZJ. 2007. E1-L2 activates both ubiquitin and FAT10. Mol Cell. Sept 21;27(6):1014-1023.
4. Groettrup M, Pelzer C, Schmidtke G, Hofmann K. 2008. Activating the ubiquitin family: UBA6 challenges the field. Trends Biochem Sci. May;33(5):230-237.
5. Lee PC, Dodart JC, Aron L, Finley LW, Bronson RT, Haigis MC, Yankner BA, Harper JW. 2013. Altered social behavior and neuronal development in mice lacking the Uba6-Use1 ubiquitin transfer system. Mol Cell. Apr 25;50(2):172-184.
6. Glausier JR, Lewis DA. 2013. Dendritic spine pathology in schizophrenia. Neuroscience. Oct 22;251:90-107.
7. Kulkarni VA, Firestein BL. 2012. The dendritic tree and brain disorders. Mol Cell Neurosci. May;50(1):10-20.
8. Kreienkamp HJ. 2008. Scaffolding proteins at the postsynaptic density: shank as the architectural framework. Handb Exp Pharmacol. (186):365-380.
9. Jana NR. 2012. Understanding the pathogenesis of Angelman syndrome through animal models. Neural Plast. 2012;710943.